Literature DB >> 15920540

Pancreatic ductal adenocarcinomas with cystic features: neither rare nor uniform.

Markus Kosmahl1, Ursula Pauser, Martin Anlauf, Günter Klöppel.   

Abstract

Cystic tumors of the pancreas are uncommon but important because of their diverse pathology and biology. Their wide spectrum also includes cystic variants of otherwise solid tumors, such as cystic endocrine tumors, cystic acinar cell carcinomas and ductal adenocarcinomas with cystic changes. In this study, we screened pancreatic ductal adenocarcinomas and their variants for macrocystic changes and determined the nature of the cysts (neoplastic vs non-neoplastic). Of 483 tumors 38 (8%) had cystic features. The largest group consisted of 24 pancreatic ductal adenocarcinomas showing a large-gland pattern with small cysts whose diameter varied between 0.5 and 1.8 cm. The epithelial lining of these cysts was generally positive for CEA (83%) and/or MUC1 (71%) and MUC5AC (74%). p53 was positive in 57% of the cases. The second group of cystic tumors (8/483) showed degenerative cystic cavities with diameters ranging between 1 and 6 cm. This group consisted of poorly differentiated pancreatic ductal adenocarcinomas, undifferentiated carcinomas with or without osteoclast-like giant cells and one adenosquamous carcinoma. In the third group of cystic tumors there were four pancreatic ductal adenocarcinomas containing tumor-related retention cysts. Their epithelial cells were positive for MUC5AC, but negative for CEA, MUC1 and p53. The fourth group consisted of two pancreatic ductal adenocarcinomas showing closely attached pseudocysts caused by tumor-associated pancreatitis. The results indicate that a considerable number of pancreatic ductal adenocarcinomas and their variants display cystic features and must therefore be considered in the differential diagnosis of cystic neoplasms of the pancreas. Moreover, not all of the cystic structures we observed were neoplastic in nature. They may also represent non-neoplastic changes, such as retention cysts and inflammatory pseudocysts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920540     DOI: 10.1038/modpathol.3800446

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  26 in total

Review 1.  Pancreas ductal adenocarcinoma with cystic features on cross-sectional imaging: radiologic-pathologic correlation.

Authors:  Seo Yeon Youn; Sung Eun Rha; Eun Sun Jung; In Seok Lee
Journal:  Diagn Interv Radiol       Date:  2018 Jan-Feb       Impact factor: 2.630

Review 2.  [Classification and malignant potential of pancreatic cystic tumors].

Authors:  I Esposito; A M Schlitter; B Sipos; G Klöppel
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

Review 3.  Differentiation of mucinous cystic neoplasm and cystic changes associated with pancreatic adenocarcinoma.

Authors:  Tae Hwan Ha; Tae Joo Jeon; Ji Young Park
Journal:  BMJ Case Rep       Date:  2013-11-05

4.  Macroscopic features predict outcome in patients with pancreatic ductal adenocarcinoma.

Authors:  Shutaro Hori; Kazuaki Shimada; Yoshinori Ino; Seiji Oguro; Minoru Esaki; Satoshi Nara; Yoji Kishi; Tomoo Kosuge; Yukinori Hattori; Aoi Sukeda; Yuko Kitagawa; Yae Kanai; Nobuyoshi Hiraoka
Journal:  Virchows Arch       Date:  2016-10-05       Impact factor: 4.064

5.  A series of 64 cases of pancreatic cystic neoplasia from an institutional study of China.

Authors:  Yuan Ji; Wen-Hui Lou; Da-Yong Jin; Tian-Tao Kuang; Meng-Su Zeng; Yun-Shan Tan; Hai-Ying Zeng; Akesu Sujie; Xiong-Zeng Zhu
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

Review 6.  Radiology of pancreatic neoplasms: An update.

Authors:  Luis Gijón de la Santa; José Antonio Pérez Retortillo; Ainhoa Camarero Miguel; Lea Marie Klein
Journal:  World J Gastrointest Oncol       Date:  2014-09-15

7.  Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes.

Authors:  Mari Mino-Kenudson; Carlos Fernández-del Castillo; Yoshifumi Baba; Nakul P Valsangkar; Andrew S Liss; Maylee Hsu; Camilo Correa-Gallego; Thun Ingkakul; Rocio Perez Johnston; Brian G Turner; Vasiliki Androutsopoulos; Vikram Deshpande; Deborah McGrath; Dushyant V Sahani; William R Brugge; Shuji Ogino; Martha B Pitman; Andrew L Warshaw; Sarah P Thayer
Journal:  Gut       Date:  2011-04-20       Impact factor: 23.059

8.  Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression.

Authors:  Jennifer Kl Colby; Russell D Klein; Mark J McArthur; Claudio J Conti; Kaoru Kiguchi; Toru Kawamoto; Penny K Riggs; Amy I Pavone; Janet Sawicki; Susan M Fischer
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

9.  Rapid shrinkage of a pancreatic serous cystadenoma with cystic degeneration: report of a case.

Authors:  Tatsuaki Sumiyoshi; Yasuo Shima; Takehiro Okabayashi; Akihito Kozuki; Toshio Nakamura; Jun Iwata; Yoshihiro Noda; Yasuhiro Hata; Yoriko Murata; Kiminori Uka; Sojiro Morita
Journal:  Surg Today       Date:  2014-07-03       Impact factor: 2.549

10.  Pancreatic ductal adenocarcinoma with intratumoral cystic lesions on MRI: correlation with histopathological findings.

Authors:  S E Yoon; J H Byun; K A Kim; H J Kim; S S Lee; S J Jang; Y-J Jang; M-G Lee
Journal:  Br J Radiol       Date:  2009-07-20       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.